Cash flows from operating activities: | |
Net loss | |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |
Depreciation expense | 5.66M |
Amortization of intangible assets | 4.62M |
Provision for doubtful accounts and service remediation reserves | 1.23M |
Stock-based compensation | 20.91M |
Stock-based compensation related to acquisition | |
Revaluation of acquisition contingent consideration | |
Release of valuation allowance | |
Amortization of convertible note issuance cost | |
Net amortization on investments | 132K |
Put option loss | |
Gain on investments classified as trading securities | |
Changes in operating assets and liabilities: | |
Accounts receivable | -6.04M |
Prepaid and other current assets | -3.37M |
Other assets | 118K |
Accounts payable | 19K |
Accrued expenses | -225K |
Accrued payroll and related expenses | 1.47M |
Accrued restructuring | 314K |
Deferred revenue | 10.1M |
Deferred income taxes | 13K |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Purchases of investments | -12.11M |
Proceeds from maturities and sale of investments | 12.88M |
Purchases of property and equipment | -7.09M |
Purchases of intangible assets | -687K |
Acquisition, net of cash acquired | -11.5M |
Change in restricted cash | |
Net cash provided by (used in) investing activities | |
Cash flows from financing activities: | |
Net proceeds from issuance of common stock | 87.14M |
Repurchases of stock | |
Repurchase of common stock from employees for payment of taxes on vesting of restricted stock units | -2.71M |
Payment of cash contingent consideration related to acquisition | -510K |
Proceeds from issuance of convertible notes, net of issuance costs | |
Repayment of debt assumed through acquisition | |
Payment of principal under capital lease | 0 |
Net cash provided by (used in) financing activities | |
Effect of exchange rates on cash and cash equivalents | |
Net increase in cash and cash equivalents | 89.88M |
Cash and cash equivalents at beginning of period | 77.23M |
Cash and cash equivalents at end of period | 167.12M |